Molecular testing and other metrics in thyroid cytology as quality‐assurance measures in evaluating variation among pathologists in the diagnosis of atypia of undetermined significance

Correlation of AUS, AUS:M, and ROM with molecular results, in addition to the distribution of pathologist TBS categories, offer a robust framework for quality assurance that illustrates deviations from target benchmarks, including shifts in interpretations from one TBS category to another. Giving feedback to pathologists regarding their practice patterns can help standardize diagnostic thresholds and meet designated target metrics.